89bio’s pegozafermin allows for a potentially best-in-disease treatment for moderate to severe Metabolic Dysfunction-Associated Steatohepatitis (MASH), one of the most…
To Advance Scientific Research in Aging, Longevity and Precision Healthcare BENGALURU, India, Sept. 9, 2025 /PRNewswire/ -- Avestagenome Project® International…
CHANGZHOU, China, Sept. 5, 2025 /PRNewswire/ -- StarCharge, a global leader of integrated energy solutions, proudly announced its strategic agreement…
Advances Manufacturing Excellence, Expands Capacity & Optimizes Footprint SUZHOU, China, Sept. 5, 2025 /PRNewswire/ -- Nexteer Automotive and the Administrative…
- The agreement includes Wealthspire Advisors, Fiducient Advisors, Newport Private Wealth and related platforms - Transaction reinforces Aon's focus on core…
Acquired brands to broaden and complement Arclin's innovation platform ALPHARETTA, Ga., Aug. 29, 2025 /PRNewswire/ -- Arclin announced today it has…
PALO ALTO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative…
Hyundai Motor Group and Royal College of Art mark a decade of collaboration with an extension to drive design innovation…
SINGAPORE, Aug. 14, 2025 /PRNewswire/ -- Docusign (Nasdaq:DOCU), the Intelligent Agreement Management company, today unveiled new AI-powered tools—including AI Contract Agents…
AHMEDABAD, India, Aug. 11, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, has announced the execution of…